Sunshine Biopharma (SBFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,652 | -1,934 | -2,492 | -708 | -556 |
| Depreciation Amortization | 4 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 81 | N/A | N/A | N/A | -8 |
| Other Working Capital | 76 | 24 | 27 | 42 | -9 |
| Other Operating Activity | 624 | 1,371 | 1,900 | 273 | 275 |
| Operating Cash Flow | $-868 | $-539 | $-564 | $-393 | $-297 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | N/A | N/A | N/A | N/A |
| Net Acquisitions | -619 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-623 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 82 | 39 | N/A | N/A | N/A |
| Debt Issued | 245 | 395 | 463 | 63 | N/A |
| Common Stock Issued | 237 | 153 | N/A | 403 | 196 |
| Other Financing Activity | 835 | 63 | 0 | 0 | 0 |
| Financing Cash Flow | $1,399 | $651 | $463 | $465 | $196 |
| Beginning Cash Position | 143 | 31 | 133 | 61 | 162 |
| End Cash Position | 51 | 143 | 31 | 133 | 61 |
| Net Cash Flow | $-93 | $112 | $-101 | $72 | $-102 |
| Free Cash Flow | |||||
| Operating Cash Flow | -868 | -539 | -564 | -393 | -297 |
| Capital Expenditure | -5 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -872 | -539 | -564 | -393 | -297 |